论文部分内容阅读
目的探讨急性心肌梗死静脉溶栓治疗中再灌注心律失常的临床情况。方法选取我院心内科2013年4月至2014年4月所收治的49例急性心肌梗死患者,确诊后及时让患者静脉滴注150万U尿激酶,口服0.3 g阿司匹林。溶栓后每日口服100 mg阿司匹林,溶栓12 h后腹壁皮下注射clexane(克塞)。结果本组49例接受溶栓治疗的患者中,再通率为79.6%(39/49)。41例患者在溶栓开始后2 h内出现心律失常。结论急性心肌梗死静脉溶栓治疗中再灌注心律失常现象较为常见,后果也较为严重,务必要予以积极处理、严密观察,尽快让患者痊愈,防止转成恶性心律失常。
Objective To investigate the clinical situation of reperfusion arrhythmia in intravenous thrombolytic therapy of acute myocardial infarction. Methods Forty-nine patients with acute myocardial infarction who were admitted to our hospital from April 2013 to April 2014 were enrolled in this study. After the diagnosis, 1.5 million Urokinase was instilled intravenously and 0.3 g aspirin was given orally. 100 mg aspirin was orally administered daily after thrombolysis and clexane was injected subcutaneously at 12 h after thrombolysis. Results Among the 49 patients receiving thrombolysis in this study, the recanalization rate was 79.6% (39/49). Thirty-one patients had arrhythmias within 2 h after the start of thrombolysis. Conclusion The reperfusion arrhythmia in intravenous thrombolytic therapy of acute myocardial infarction is more common, the consequences are more serious, it is necessary to be actively treated, closely observe the patient cured as soon as possible to prevent the conversion of malignant arrhythmia.